MHRA — Medicines and Healthcare products Regulatory Agency Press Releases — RSS Feed & Live Monitoring
PPN World tracks the MHRA — Medicines and Healthcare products Regulatory Agency RSS feed in real time — 7 releases indexed over the last 30 days, the newest arrived 2 d ago. Follow it with saved-search alerts, AI summaries, and full-text search.
Free daily email
What breaks tomorrow
Tomorrow’s key world events from the PPN World agenda (central banks, data releases, elections, summits), in your inbox every evening at 17:00 UTC.
One email a day. No account needed. Unsubscribe in one click.
About this feed
MHRA — Medicines and Healthcare products Regulatory Agency is one of the 1,400+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed under United Kingdom in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. MHRA — Medicines and Healthcare products Regulatory Agency is a low-volume specialist wire — 7 releases over the last 30 days: the kind of source worth an alert rather than a scroll.
Track MHRA — Medicines and Healthcare products Regulatory Agency in real time in PPN World
Every MHRA — Medicines and Healthcare products Regulatory Agency release lands in the cockpit seconds after it publishes — deduplicated, classified, with saved-search alerts and AI summaries, alongside 1,400+ other wires.
Create free account →Latest MHRA — Medicines and Healthcare products Regulatory Agency press releases
- MHRA appoints senior NHS executive as new Chief Finance and Commercial Officer2 d ago
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed a new Chief Financial and Commercial Officer to drive forward the financial aspects of its new five-year strategy.
- Government backs modernisation of gene therapy definitions3 d ago
Proposed changes will provide clearer regulatory pathway for certain synthetic gene therapies, supporting life sciences innovation while maintaining safety.
- New MHRA service to support medicines innovation and strengthen UK manufacturing4 d ago
AdvanceGxP will give developers earlier practical support for advanced manufacturing technologies, accelerating patient access to innovative medicines while strengthening UK manufacturing.
- MHRA launches new programme to tackle evidence gaps on women’s health6 d ago
Women’s Health Programme aims to support innovation in women’s health and better understand how the risks and benefits of medicines and medical devices may differ for women.
- MHRA: services during Microsoft outage8 d ago
We have been experiencing problems sending and receiving emails.
- MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer10 d ago
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for the treatment of adults with squamous cell carcinoma of the anal canal (SCAC).
- Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway13 d ago
Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare produc…
- MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulation16 d ago
New plan will broaden participation and make clearer how patient experience informs regulatory decisions, safety and innovation
- MHRA guidance on its assessment of non-clinical data generated outside OECD system17 d ago
MHRA issues new guidance on its approach to clinical trial applications that rely on non-clinical safety data generated outside the OECD Mutual Acceptance of Data system.
- Clinical trials for medicines: Inclusion and Diversity Plan pilot findings published19 d ago
The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Dive…
- MHRA launches patient safety essay competition for MedSafetyWeek20 d ago
The MHRA reminds patients, parents, carers and healthcare professionals to report suspected side effects through the Yellow Card scheme for MedSafetyWeek 2026.
- Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders22 d ago
MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.
The newest releases on this wire stream live for PPN World members.